Designed for the restorative general dentist, Biolase’s Waterlase C100 is said to provide clinical procedures including cavity preparation, early stage periodontal therapy and soft tissue procedures with more
The test is based upon Zeus’s own proprietary technology utilizing the enrichment and nucleic acid amplification of a target pathogen. In addition to significantly improving assay performance over
Under this agreement, Sangamo will provide a non-exclusive, worldwide research license for the use of its proprietary zinc finger nuclease (ZFN) technology in the development of transgenic animals.
Pearl 1 is fully enrolled with over 475 non-dialysis patients from over 70 sites in the US. The Hematide Phase III program, involving a total of approximately 2,400
The new facility will be used for manufacturing, R&D and administrative functions. It is especially suited to support FDA-compliant manufacturing of the company’s human stem cell products for
According to the company, these peptides were specifically designed to elicit a T cell response targeting CD133 positive cancer stem cells that have been identified in a number
Mr Frank will remain as president and CEO of Nexcore Technology, an original equipment manufacturer (OEM) of medical devices with headquarters in Waldwick, New Jersey. Prior to founding
The clinical study is a Phase Ib placebo-controlled, single-center dose ranging study. The primary objectives are to evaluate safety and tolerability and to determine preliminary pharmacokinetics of AZX100
The study results showed that senicapoc was well tolerated at all doses tested and in preliminary analyses exhibited predictable and dose proportional pharmacokinetics consistent with once-daily dosing. Additionally,
Using an animal model of endotoxemia, a condition in which there is a substantial increase in the levels of inflammatory cytokines and chemokines in serum, CGEN-25007 was shown
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.